Search
for
Sort by
Research 481–510 of 517
- Efficacy of myo-inositol in the treatment of cutaneous disorders in young women with polycystic ovary syndrome
- Androgen receptor gene CAG repeat polymorphism in women with polycystic ovary syndrome
- Expression of AKT1 along with AKT2 in granulosa-lutein cells of hyperandrogenic PCOS patients
- Skin as a Window to Endocrine Dysfunction: Dermatological and Metabolic Interactions in Polycystic Ovary Syndrome
- Cutaneous Clues to Metabolic Dysfunction: Dermatological Manifestations of Diabetes and Insulin Resistance in Clinical Practice
- Differential plasma proteome analysis reveals key proteins associated with insulin resistance in acne vulgaris patients
- Insulin Resistance and Polycystic Ovary Syndrome
- Gender difference in the relationship between the ferritin and homeostasis model assessment of insulin resistance in non-diabetic Korean adults
- Early onset androgenic alopecia as the male phenotypic equivalent of polycystic ovarian syndrome is associated in high oxidative stress
- Definition criteria and diagnostic assessments
- Obesity and hyperandrogenism are implicated with anxiety, depression and food cravings in women with polycystic ovary syndrome.
- Serum level of calprotectin as a new inflammatory marker in patients with alopacia areata
- PHILADELPHIA DERMATOLOGICAL SOCIETY
- Nonalcoholic fatty liver disease and polycystic ovary syndrome
- The Effect of Alfacalcidiol and Metformin on Phenotype Manifestations in Women with Polycystic Ovary Syndrome – a Preliminary Study
- Overexpression of Lnk in the Ovaries Is Involved in Insulin Resistance in Women With Polycystic Ovary Syndrome
- Green Tea as a Supportive Therapy for PCOS: Evaluating Its Impact on Symptom Relief
- Metabolic effects of duodenal mucosal resurfacing on insulin resistant women with polycystic ovary syndrome
- REPRODUCTIVE HORMONE LEVELS AND METABOLIC SYNDROME IN WOMEN WITH POLYCYSTIC OVARY SYNDROME IN SANA'A, YEMEN
- METABOLIC, REPRODUCTIVE OUTCOMES AND SIDE EFFECTS AFTER THE ADMINISTRATION OF 100 MG DEHYDROEPIANDROSTERONE (DHEA) IN WOMEN WITH AN ADEQUATE OVARIAN RESERVE
- miR-761-hepcidin/Gpx4 pathway contribute to unexplained liver dysfunction in polycystic ovary syndrome by regulating liver iron overload and ferroptosis
- ABCD1 Gene Mutations: Mechanisms and Management of Adrenomyeloneuropathy
- Polycystic Ovary Syndrome in the Context of Pituitary Adenomas: Prevalence, Pathophysiology and Clinical Management
- Mental Health as Assessed by the Symptom Checklist 90 (SCL-90) Scores in Women with and Without Polycystic Ovary Syndrome
- Efficacy and safety of SGLT2 inhibitor on insulin resistance and hyperglycemia in Werner syndrome—A case report
- Serum Gelsolin Levels in PCOS-Related Androgenetic Alopecia
- Exercise activates the PI3K-AKT signal pathway by decreasing the expression of 5α-reductase type 1 in PCOS rats
- Cutaneous manifestations of polycystic ovary syndrome: A cross-sectional clinical study
- Metabolic Syndrome, Hepatic Steatosis and Testosterone: A Matter of Sex
- <i>IGF2BP2</i> and <i>IGFBP3</i> Genotypes, Haplotypes, and Genetic Models Studies in Polycystic Ovary Syndrome